Detalles de la búsqueda
1.
Short-term response to alemtuzumab in CD52-positive secondary histiocytic sarcoma in a child: Is it time to consider new targets?
Pediatr Hematol Oncol
; 38(1): 89-96, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32897114
2.
The translational gap for gene therapies in low- and middle-income countries.
Sci Transl Med
; 16(746): eadn1902, 2024 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38718130
3.
Umbilical Cord Mesenchymal Stromal Cells for Steroid-Refractory Acute Graft-versus-Host Disease.
Pharmaceuticals (Basel)
; 16(4)2023 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37111270
4.
Cytokines as an important player in the context of CAR-T cell therapy for cancer: Their role in tumor immunomodulation, manufacture, and clinical implications.
Front Immunol
; 13: 947648, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36172343
5.
Long-Term Effects of Allogeneic Hematopoietic Stem Cell Transplantation on Systemic Inflammation in Sickle Cell Disease Patients.
Front Immunol
; 12: 774442, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34956203
6.
Polymorphisms in Inflammatory Genes Modulate Clinical Complications in Patients With Sickle Cell Disease.
Front Immunol
; 11: 2041, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33013863
7.
Safety and efficacy of a new academic CD19-directed CAR-T cell for refractory/relapsed non-Hodgkin lymphoma and acute lymphoblastic leukemia in Brazil.
Bone Marrow Transplant
; 2024 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38615142
Resultados
1 -
7
de 7
1
Próxima >
>>